Immunological monitoring of anticancer vaccines in clinical trials.
about
Lost in translation: animal models and clinical trials in cancer treatmentTrial Watch: Proteasomal inhibitors for anticancer therapyPhase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancerCytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentTherapeutic Vaccine Strategies against Human Papillomavirus.Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.The FDA guidance on therapeutic cancer vaccines: the need for revision to include preventive cancer vaccines or for a new guidance dedicated to themSystematic identification of genes with a cancer-testis expression pattern in 19 cancer types.Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist.Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma.Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patientsMonitoring the immune competence of cancer patients to predict outcome.Counteracting antibiotic resistance: breaking barriers among antibacterial strategies.Therapeutic vaccines for cancer: an overview of clinical trials.Stem cell in alternative treatments for brain tumors: potential for gene delivery.The importance of the tumor microenvironment in the therapeutic management of cancer.Monocyte targeting and activation by cationic liposomes formulated with a TLR7 agonist.
P2860
Q27000792-BBEDD2A1-523B-47EA-ADD3-0163935C11EEQ28082910-EAC5D754-7A1E-4724-8198-4B8A43757058Q33587863-857A6851-CF7B-408B-96AA-4B5EEE2049AEQ33691858-D3BACEB6-B9D1-4950-9AFC-2DC2D6C08583Q34410500-F0C3783A-4DBA-4757-B869-5493E4F7A612Q35826752-8F3C91DE-4B96-4B11-95F3-FAA7599B4C05Q36114649-53738D5D-6A7C-482B-B96F-9FDD532127E3Q36248790-E1014C1F-F493-49FE-9719-0261165B04F0Q36534662-260E1F1D-8905-4273-9E24-20F4AE10717BQ36777133-19DEEF60-6553-4E57-AE37-7CD4ED45ECB4Q36977760-ACAB1A2A-6126-4D89-B823-87475D9D603EQ37530591-560C3533-711E-4716-8DE4-AD18081D8722Q38184391-4AD0C709-4462-4883-B3B0-A3CBFC5218C3Q38216443-5719B74E-940E-4380-9BE2-15FE618F2891Q38227030-68025889-0E36-45FF-8791-614242FDD5B1Q38521752-58E21A29-EA18-4CDA-9F42-1ED8B6604C08Q38534294-33B734D5-2A9A-4AB2-8CBC-458C6181AC40Q39038777-9D108FB5-FBB1-4650-91B8-686F7340950B
P2860
Immunological monitoring of anticancer vaccines in clinical trials.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Immunological monitoring of anticancer vaccines in clinical trials.
@en
Immunological monitoring of anticancer vaccines in clinical trials.
@nl
type
label
Immunological monitoring of anticancer vaccines in clinical trials.
@en
Immunological monitoring of anticancer vaccines in clinical trials.
@nl
prefLabel
Immunological monitoring of anticancer vaccines in clinical trials.
@en
Immunological monitoring of anticancer vaccines in clinical trials.
@nl
P2860
P356
P1433
P1476
Immunological monitoring of anticancer vaccines in clinical trials.
@en
P2093
Atsushi Aruga
Chizuru Ogi
P2860
P304
P356
10.4161/ONCI.26012
P577
2013-08-23T00:00:00Z